Literature DB >> 14556667

Projection of lung cancer mortality in Japan.

Satoshi Kaneko1, Koichi B Ishikawa, Itsuro Yoshimi, Tomomi Marugame, Chisato Hamashima, Ken-Ichi Kamo, Shoichi Mizuno, Tomotaka Sobue.   

Abstract

According to the National Vital Statistics data, age-standardized mortality rates (ASRs) of lung cancer have shown slightly declining trends in Japan for both men and women. In order to evaluate whether this tendency will continue, a Bayesian age-period-cohort (APC) model was applied using the National Vital Statistics data from 1952 to 2001. In the projection, a Gaussian autoregressive prior model was applied to smooth age, period, and cohort effects from its 2 immediate predecessors by extrapolation. Posterior distributions from which we drew inferences on mortality rates were derived from 15,000 iterations using 5000 burn-in iterations. We defined the median of the iterated values as the overall summary mortality rate of the iterated results. Our results suggest that the number of deaths due to lung cancer will double for men and women during the next 3 decades due to the aging of the baby-boomer generation (individuals who were born between 1947 and 1951). Currently declining trends in some age groups will reverse and start to increase again in the next decades. However, for recent birth cohorts, the results of the projection varied according to whether the data set included early age group mortality or not. Lung cancer mortality in the future depends on the risk factors engaged in by today's young people, especially smoking. Strong promotion of anti-smoking measures and careful surveillance for lung cancer are needed.

Entities:  

Mesh:

Year:  2003        PMID: 14556667     DOI: 10.1111/j.1349-7006.2003.tb01376.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  8 in total

1.  Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy?

Authors:  Toshio Kato; Masahiro Morise; Masahiko Ando; Eiji Kojima; Tomohiko Ogasawara; Ryujiro Suzuki; Joe Shindoh; Masami Matsumoto; Yasuteru Sugino; Masahiro Ogawa; Yasuhiro Nozaki; Tetsunari Hase; Masashi Kondo; Hiroshi Saito; Yoshinori Hasegawa
Journal:  J Cancer Res Clin Oncol       Date:  2016-05-11       Impact factor: 4.553

2.  Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer.

Authors:  Yuri Shimanuki; Kazuhisa Takahashi; Ri Cui; Satoshi Hori; Fumiyuki Takahashi; Hideaki Miyamoto; Yoshinosuke Fukurchi
Journal:  Lung       Date:  2005 Jan-Feb       Impact factor: 2.584

3.  How Well Have Projected Lung Cancer Rates Predicted the Actual Observed Rates?

Authors:  Qingwei Luo; Julia Steinberg; Xue Qin Yu; Michael Caruana; Karen Canfell; Dianne L O’Connell
Journal:  Asian Pac J Cancer Prev       Date:  2021-02-01

4.  Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014.

Authors:  Yusuke Takagi; Yukio Hosomi; Fumihiro Oshita; Hiroaki Okamoto; Nobuhiko Seki; Koichi Minato; Hiromi Aono; Kouzo Yamada; Yusuke Okuma; Naoya Hida; Takahiko Sakamoto; Yosuke Miura; Makiko Yomota; Akira Satoh; Hideo Kunitoh; Kentaro Sakamaki; Masahiko Shibuya; Koshiro Watanabe
Journal:  BMC Cancer       Date:  2015-10-19       Impact factor: 4.430

5.  Gender difference as a prognostic factor in patients undergoing resection of non-small cell lung cancer.

Authors:  Takeshi Hanagiri; Kenji Sugio; Hidetaka Uramoto; Tetsuya So; Yoshinobu Ichiki; Masakazu Sugaya; Kenji Ono; Manabu Yasuda; Tadahiro Nozoe; Kosei Yasumoto
Journal:  Surg Today       Date:  2007-06-26       Impact factor: 2.540

6.  Cross-national comparison of sex differences in health and mortality in Denmark, Japan and the US.

Authors:  Anna Oksuzyan; Eileen Crimmins; Yasuhiko Saito; Angela O'Rand; James W Vaupel; Kaare Christensen
Journal:  Eur J Epidemiol       Date:  2010-05-22       Impact factor: 8.082

7.  Trends in lung cancer incidence by histological type in Osaka, Japan.

Authors:  Yasuhiro Toyoda; Tomio Nakayama; Akiko Ioka; Hideaki Tsukuma
Journal:  Jpn J Clin Oncol       Date:  2008-08-09       Impact factor: 3.019

8.  Updated information on risk factors for lung cancer: findings from the JACC Study.

Authors:  Kenji Wakai; Masahiko Ando; Kotaro Ozasa; Yoshinori Ito; Koji Suzuki; Yoshikazu Nishino; Shin-ichi Kuriyama; Nao Seki; Takaaki Kondo; Yoshiyuki Watanabe; Yoshiyuki Ohno; Akiko Tamakoshi
Journal:  J Epidemiol       Date:  2005-06       Impact factor: 3.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.